CombiMatrix Corporation to Release Second Quarter Financial Results on August 6, 2014
July 30, 2014 16:05 ET
|
CombiMatrix Corporation
IRVINE, Calif., July 30, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its second quarter 2014 financial results on Wednesday, August 6, 2014....
CombiMatrix Signs Contract With Stratose Networks Division, One of the Largest Directly-Managed PPO Networks in U.S.
July 22, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., July 22, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...
CombiMatrix's Pediatric Development Disorders Analysis Test Granted Conditional Approval From New York State Department of Health
July 15, 2014 08:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., July 15, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for developmental disorders and cancer...
CombiMatrix Announces LI Path Now Offering Company's Miscarriage Analysis Testing
May 13, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., May 13, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...
CombiMatrix Corporation Reports Record Revenues for 2014 First Quarter
May 07, 2014 06:00 ET
|
CombiMatrix Corporation
Prenatal Microarray Test Volumes and Revenues Reach Record Levels,
Up Year-over-Year 60% and 34%, Respectively
Total Microarray Revenue Up Sequentially 9% from Q4 2013 to Q1 2014
IRVINE,...
CombiMatrix Corporation to Release First Quarter Financial Results on May 7, 2014
April 30, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 30, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its first quarter 2014 financial results on Wednesday, May 7, 2014....
CombiMatrix Names Trilochan Sahoo, M.D., Director of Cytogenetics
April 09, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., April 9, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...
CombiMatrix Announces Partnership With American Pathology Partners to Provide Products of Conception Testing
March 13, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 13, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...
CombiMatrix Hires R. Weslie Tyson, M.D., as Chief Medical Officer
March 10, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 10, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...
CombiMatrix to Present at the 26th Annual ROTH Conference
March 04, 2014 06:00 ET
|
CombiMatrix Corporation
IRVINE, Calif., March 4, 2014 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and...